THOMAS MOLTON: Open Payments
NPI 1144636648 · GRANBURY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 13 payments from 12 companies in 2025. Trend: 2023 $18 · 2024 $326 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| ABBVIE INC. | 1 | $33 |
| Celgene Corporation | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $27 |
| PFIZER INC. | 1 | $24 |
| Karyopharm Therapeutics Inc. | 1 | $23 |
| BeOne Medicines USA, Inc. | 1 | $21 |
| ARRAY BIOPHARMA INC | 1 | $21 |
| GENZYME CORPORATION | 1 | $18 |
Products named: LYNOZYFIC, EPKINLY, REBLOZYL, DARZALEX, BOSULIF, LYNPARZA, XPOVIO, TEVIMBRA.
Industry payments across TX — which companies pay providers there.
